APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atypical Antipsychotic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atypical Antipsychotic Drugs Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchAtypical Antipsychotic Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Atypical Antipsychotic Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Atypical Antipsychotic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atypical Antipsychotic Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Atypical Antipsychotic Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Atypical Antipsychotic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atypical Antipsychotic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atypical Antipsychotic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atypical Antipsychotic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atypical Antipsychotic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atypical Antipsychotic Drugs include Sun Pharmaceutical Industries, Johnson and Johnson, Qilu Pharmaceutical, Novartis AG, Eil Lilly and Company, Pfizer, GlaxoSmithKline, AstraZeneca and Sumitomo Dainippon Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atypical Antipsychotic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atypical Antipsychotic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Atypical Antipsychotic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atypical Antipsychotic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atypical Antipsychotic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atypical Antipsychotic Drugs sales, projected growth trends, production technology, application and end-user industry.

Atypical Antipsychotic Drugs Segment by Company

Sun Pharmaceutical Industries

Johnson and Johnson

Qilu Pharmaceutical

Novartis AG

Eil Lilly and Company

Pfizer

GlaxoSmithKline

AstraZeneca

Sumitomo Dainippon Pharma

Sanis Health

Cardinal Health

Bristol-Myers Squibb Company

Allergan

Atypical Antipsychotic Drugs Segment by Type

Olanzapine

Quetiapine

Risperidone

Ziprasidone

Others

Atypical Antipsychotic Drugs Segment by Application

Schizoaffective Disorder

Schizophrenia

Bipolar I Disorder

Major Depressive Disorder (MDD)

Atypical Antipsychotic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atypical Antipsychotic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atypical Antipsychotic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atypical Antipsychotic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atypical Antipsychotic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atypical Antipsychotic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atypical Antipsychotic Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Olanzapine Major Manufacturers Table 3. Quetiapine Major Manufacturers Table 4. Risperidone Major Manufacturers Table 5. Ziprasidone Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Schizoaffective Disorder Major Manufacturers Table 9. Schizophrenia Major Manufacturers Table 10. Bipolar I Disorder Major Manufacturers Table 11. Major Depressive Disorder (MDD) Major Manufacturers Table 12. Atypical Antipsychotic Drugs Industry Trends Table 13. Atypical Antipsychotic Drugs Industry Drivers Table 14. Atypical Antipsychotic Drugs Industry Opportunities and Challenges Table 15. Atypical Antipsychotic Drugs Industry Restraints Table 16. Global Atypical Antipsychotic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Atypical Antipsychotic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Atypical Antipsychotic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2021-2026) Table 20. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2027-2032) Table 21. Global Atypical Antipsychotic Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Atypical Antipsychotic Drugs Sales by Region (2021-2026) & (k units) Table 23. Global Atypical Antipsychotic Drugs Sales by Region (2027-2032) & (k units) Table 24. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2021-2026) Table 25. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2027-2032) Table 26. Global Atypical Antipsychotic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Atypical Antipsychotic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Atypical Antipsychotic Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Atypical Antipsychotic Drugs Sales Market Share by Manufacturers (2021-2026) Table 30. Global Atypical Antipsychotic Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Atypical Antipsychotic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Atypical Antipsychotic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Atypical Antipsychotic Drugs Manufacturers, Product Type & Application Table 34. Global Atypical Antipsychotic Drugs Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Atypical Antipsychotic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Atypical Antipsychotic Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Atypical Antipsychotic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2021-2026) Table 41. Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2027-2032) Table 42. Global Atypical Antipsychotic Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (k units) Table 44. Global Atypical Antipsychotic Drugs Sales by Type (2027-2032) & (k units) Table 45. Global Atypical Antipsychotic Drugs Sales Market Share by Type (2021-2026) Table 46. Global Atypical Antipsychotic Drugs Sales Market Share by Type (2027-2032) Table 47. Global Atypical Antipsychotic Drugs Price by Type (2021-2026) & (US$/unit) Table 48. Global Atypical Antipsychotic Drugs Price by Type (2027-2032) & (US$/unit) Table 49. Global Atypical Antipsychotic Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Atypical Antipsychotic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2021-2026) Table 53. Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2027-2032) Table 54. Global Atypical Antipsychotic Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (k units) Table 56. Global Atypical Antipsychotic Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Atypical Antipsychotic Drugs Sales Market Share by Application (2021-2026) Table 58. Global Atypical Antipsychotic Drugs Sales Market Share by Application (2027-2032) Table 59. Global Atypical Antipsychotic Drugs Price by Application (2021-2026) & (US$/unit) Table 60. Global Atypical Antipsychotic Drugs Price by Application (2027-2032) & (US$/unit) Table 61. Sun Pharmaceutical Industries Company Information Table 62. Sun Pharmaceutical Industries Business Overview Table 63. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Portfolio Table 65. Sun Pharmaceutical Industries Recent Development Table 66. Johnson and Johnson Company Information Table 67. Johnson and Johnson Business Overview Table 68. Johnson and Johnson Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Johnson and Johnson Atypical Antipsychotic Drugs Product Portfolio Table 70. Johnson and Johnson Recent Development Table 71. Qilu Pharmaceutical Company Information Table 72. Qilu Pharmaceutical Business Overview Table 73. Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Portfolio Table 75. Qilu Pharmaceutical Recent Development Table 76. Novartis AG Company Information Table 77. Novartis AG Business Overview Table 78. Novartis AG Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis AG Atypical Antipsychotic Drugs Product Portfolio Table 80. Novartis AG Recent Development Table 81. Eil Lilly and Company Company Information Table 82. Eil Lilly and Company Business Overview Table 83. Eil Lilly and Company Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Eil Lilly and Company Atypical Antipsychotic Drugs Product Portfolio Table 85. Eil Lilly and Company Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Atypical Antipsychotic Drugs Product Portfolio Table 90. Pfizer Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Atypical Antipsychotic Drugs Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. AstraZeneca Atypical Antipsychotic Drugs Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Sumitomo Dainippon Pharma Company Information Table 102. Sumitomo Dainippon Pharma Business Overview Table 103. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Portfolio Table 105. Sumitomo Dainippon Pharma Recent Development Table 106. Sanis Health Company Information Table 107. Sanis Health Business Overview Table 108. Sanis Health Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Sanis Health Atypical Antipsychotic Drugs Product Portfolio Table 110. Sanis Health Recent Development Table 111. Cardinal Health Company Information Table 112. Cardinal Health Business Overview Table 113. Cardinal Health Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Cardinal Health Atypical Antipsychotic Drugs Product Portfolio Table 115. Cardinal Health Recent Development Table 116. Bristol-Myers Squibb Company Company Information Table 117. Bristol-Myers Squibb Company Business Overview Table 118. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Portfolio Table 120. Bristol-Myers Squibb Company Recent Development Table 121. Allergan Company Information Table 122. Allergan Business Overview Table 123. Allergan Atypical Antipsychotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Allergan Atypical Antipsychotic Drugs Product Portfolio Table 125. Allergan Recent Development Table 126. North America Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Atypical Antipsychotic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (k units) Table 129. North America Atypical Antipsychotic Drugs Sales by Type (2027-2032) & (k units) Table 130. North America Atypical Antipsychotic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 131. North America Atypical Antipsychotic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 132. North America Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Atypical Antipsychotic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (k units) Table 135. North America Atypical Antipsychotic Drugs Sales by Application (2027-2032) & (k units) Table 136. North America Atypical Antipsychotic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 137. North America Atypical Antipsychotic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 138. North America Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. North America Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (k units) Table 143. North America Atypical Antipsychotic Drugs Sales by Country (2027-2032) & (k units) Table 144. North America Atypical Antipsychotic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 145. North America Atypical Antipsychotic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 146. United States Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 147. Canada Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 148. Mexico Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 149. Europe Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Atypical Antipsychotic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (k units) Table 152. Europe Atypical Antipsychotic Drugs Sales by Type (2027-2032) & (k units) Table 153. Europe Atypical Antipsychotic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 154. Europe Atypical Antipsychotic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 155. Europe Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Atypical Antipsychotic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (k units) Table 158. Europe Atypical Antipsychotic Drugs Sales by Application (2027-2032) & (k units) Table 159. Europe Atypical Antipsychotic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 160. Europe Atypical Antipsychotic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 161. Europe Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 165. Europe Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (k units) Table 166. Europe Atypical Antipsychotic Drugs Sales by Country (2027-2032) & (k units) Table 167. Europe Atypical Antipsychotic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 168. Europe Atypical Antipsychotic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 169. Germany Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 170. France Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 171. U.K. Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 172. Italy Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 173. Russia Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 174. Spain Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 175. Netherlands Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 176. Switzerland Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 177. Sweden Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 178. Poland Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 179. China Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 180. China Atypical Antipsychotic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 181. China Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (k units) Table 182. China Atypical Antipsychotic Drugs Sales by Type (2027-2032) & (k units) Table 183. China Atypical Antipsychotic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 184. China Atypical Antipsychotic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 185. China Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 186. China Atypical Antipsychotic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 187. China Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (k units) Table 188. China Atypical Antipsychotic Drugs Sales by Application (2027-2032) & (k units) Table 189. China Atypical Antipsychotic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 190. China Atypical Antipsychotic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 191. Asia Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 192. Asia Atypical Antipsychotic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 193. Asia Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (k units) Table 194. Asia Atypical Antipsychotic Drugs Sales by Type (2027-2032) & (k units) Table 195. Asia Atypical Antipsychotic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 196. Asia Atypical Antipsychotic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 197. Asia Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Atypical Antipsychotic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (k units) Table 200. Asia Atypical Antipsychotic Drugs Sales by Application (2027-2032) & (k units) Table 201. Asia Atypical Antipsychotic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 202. Asia Atypical Antipsychotic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 203. Asia Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Asia Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Asia Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 207. Asia Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (k units) Table 208. Asia Atypical Antipsychotic Drugs Sales by Country (2027-2032) & (k units) Table 209. Asia Atypical Antipsychotic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 210. Asia Atypical Antipsychotic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 211. Japan Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 212. South Korea Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 213. India Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 214. Australia Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 215. Taiwan Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 216. Southeast Asia Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 217. SAMEA Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Atypical Antipsychotic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (k units) Table 220. SAMEA Atypical Antipsychotic Drugs Sales by Type (2027-2032) & (k units) Table 221. SAMEA Atypical Antipsychotic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 222. SAMEA Atypical Antipsychotic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 223. SAMEA Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 224. SAMEA Atypical Antipsychotic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 225. SAMEA Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (k units) Table 226. SAMEA Atypical Antipsychotic Drugs Sales by Application (2027-2032) & (k units) Table 227. SAMEA Atypical Antipsychotic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 228. SAMEA Atypical Antipsychotic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 229. SAMEA Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. SAMEA Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. SAMEA Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. SAMEA Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 233. SAMEA Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (k units) Table 234. SAMEA Atypical Antipsychotic Drugs Sales by Country (2027-2032) & (k units) Table 235. SAMEA Atypical Antipsychotic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 236. SAMEA Atypical Antipsychotic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 237. Brazil Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 238. Argentina Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 239. Chile Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 240. Colombia Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 241. Peru Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 242. Saudi Arabia Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 243. Israel Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 244. UAE Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 245. Turkey Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 246. Iran Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 247. Egypt Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Atypical Antipsychotic Drugs Distributors List Table 251. Atypical Antipsychotic Drugs Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Atypical Antipsychotic Drugs Image Figure 2. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atypical Antipsychotic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Olanzapine Image Figure 5. Quetiapine Image Figure 6. Risperidone Image Figure 7. Ziprasidone Image Figure 8. Others Image Figure 9. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Atypical Antipsychotic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Schizoaffective Disorder Image Figure 12. Schizophrenia Image Figure 13. Bipolar I Disorder Image Figure 14. Major Depressive Disorder (MDD) Image Figure 15. Global Atypical Antipsychotic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Atypical Antipsychotic Drugs Revenue (2021-2032) & (US$ Million) Figure 17. Global Atypical Antipsychotic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Atypical Antipsychotic Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2021-2032) Figure 20. Global Atypical Antipsychotic Drugs Sales (2021-2032) & (k units) Figure 21. Global Atypical Antipsychotic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Atypical Antipsychotic Drugs Sales YoY (2021-2032) & (k units) Figure 24. Europe Atypical Antipsychotic Drugs Sales YoY (2021-2032) & (k units) Figure 25. China Atypical Antipsychotic Drugs Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Atypical Antipsychotic Drugs Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Atypical Antipsychotic Drugs Sales YoY (2021-2032) & (k units) Figure 28. Global Atypical Antipsychotic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Atypical Antipsychotic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Atypical Antipsychotic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Atypical Antipsychotic Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2021-2032) Figure 34. Global Atypical Antipsychotic Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Atypical Antipsychotic Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Atypical Antipsychotic Drugs Sales Market Share by Type (2021-2032) Figure 37. Global Atypical Antipsychotic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Atypical Antipsychotic Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2021-2032) Figure 40. Global Atypical Antipsychotic Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Atypical Antipsychotic Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Atypical Antipsychotic Drugs Sales Market Share by Application (2021-2032) Figure 43. North America Atypical Antipsychotic Drugs Revenue Share by Type (2021-2032) Figure 44. North America Atypical Antipsychotic Drugs Sales Share by Type (2021-2032) Figure 45. North America Atypical Antipsychotic Drugs Revenue Share by Application (2021-2032) Figure 46. North America Atypical Antipsychotic Drugs Sales Share by Application (2021-2032) Figure 47. North America Atypical Antipsychotic Drugs Revenue Share by Country (2021-2032) Figure 48. North America Atypical Antipsychotic Drugs Sales Share by Country (2021-2032) Figure 49. Europe Atypical Antipsychotic Drugs Revenue Share by Type (2021-2032) Figure 50. Europe Atypical Antipsychotic Drugs Sales Share by Type (2021-2032) Figure 51. Europe Atypical Antipsychotic Drugs Revenue Share by Application (2021-2032) Figure 52. Europe Atypical Antipsychotic Drugs Sales Share by Application (2021-2032) Figure 53. Europe Atypical Antipsychotic Drugs Revenue Share by Country (2021-2032) Figure 54. Europe Atypical Antipsychotic Drugs Sales Share by Country (2021-2032) Figure 55. China Atypical Antipsychotic Drugs Revenue Share by Type (2021-2032) Figure 56. China Atypical Antipsychotic Drugs Sales Share by Type (2021-2032) Figure 57. China Atypical Antipsychotic Drugs Revenue Share by Application (2021-2032) Figure 58. China Atypical Antipsychotic Drugs Sales Share by Application (2021-2032) Figure 59. Asia Atypical Antipsychotic Drugs Revenue Share by Type (2021-2032) Figure 60. Asia Atypical Antipsychotic Drugs Sales Share by Type (2021-2032) Figure 61. Asia Atypical Antipsychotic Drugs Revenue Share by Application (2021-2032) Figure 62. Asia Atypical Antipsychotic Drugs Sales Share by Application (2021-2032) Figure 63. Asia Atypical Antipsychotic Drugs Revenue Share by Country (2021-2032) Figure 64. Asia Atypical Antipsychotic Drugs Sales Share by Country (2021-2032) Figure 65. SAMEA Atypical Antipsychotic Drugs Revenue Share by Type (2021-2032) Figure 66. SAMEA Atypical Antipsychotic Drugs Sales Share by Type (2021-2032) Figure 67. SAMEA Atypical Antipsychotic Drugs Revenue Share by Application (2021-2032) Figure 68. SAMEA Atypical Antipsychotic Drugs Sales Share by Application (2021-2032) Figure 69. SAMEA Atypical Antipsychotic Drugs Revenue Share by Country (2021-2032) Figure 70. SAMEA Atypical Antipsychotic Drugs Sales Share by Country (2021-2032) Figure 71. Atypical Antipsychotic Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Atypical Antipsychotic Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Olanzapine
  • Quetiapine
  • Risperidone
  • Ziprasidone
  • Others
Applications
  • Schizoaffective Disorder
  • Schizophrenia
  • Bipolar I Disorder
  • Major Depressive Disorder (MDD)
Companies covered
  • Sun Pharmaceutical Industries
  • Johnson and Johnson
  • Qilu Pharmaceutical
  • Novartis AG
  • Eil Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Sumitomo Dainippon Pharma
  • Sanis Health
  • Cardinal Health
  • Bristol-Myers Squibb Company
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atypical Antipsychotic Drugs Market by Type
  3. 1.2.1 Global Atypical Antipsychotic Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Olanzapine
  5. 1.2.3 Quetiapine
  6. 1.2.4 Risperidone
  7. 1.2.5 Ziprasidone
  8. 1.2.6 Others
  9. 1.3 Atypical Antipsychotic Drugs Market by Application
  10. 1.3.1 Global Atypical Antipsychotic Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Schizoaffective Disorder
  12. 1.3.3 Schizophrenia
  13. 1.3.4 Bipolar I Disorder
  14. 1.3.5 Major Depressive Disorder (MDD)
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Atypical Antipsychotic Drugs Market Dynamics
  1. 2.1 Atypical Antipsychotic Drugs Industry Trends
  2. 2.2 Atypical Antipsychotic Drugs Industry Drivers
  3. 2.3 Atypical Antipsychotic Drugs Industry Opportunities and Challenges
  4. 2.4 Atypical Antipsychotic Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atypical Antipsychotic Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atypical Antipsychotic Drugs Revenue by Region
  3. 3.2.1 Global Atypical Antipsychotic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atypical Antipsychotic Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Atypical Antipsychotic Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atypical Antipsychotic Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atypical Antipsychotic Drugs Sales by Region
  9. 3.4.1 Global Atypical Antipsychotic Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atypical Antipsychotic Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Atypical Antipsychotic Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Atypical Antipsychotic Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atypical Antipsychotic Drugs Revenue by Manufacturers
  2. 4.1.1 Global Atypical Antipsychotic Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atypical Antipsychotic Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atypical Antipsychotic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atypical Antipsychotic Drugs Sales by Manufacturers
  6. 4.2.1 Global Atypical Antipsychotic Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atypical Antipsychotic Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atypical Antipsychotic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atypical Antipsychotic Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atypical Antipsychotic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atypical Antipsychotic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atypical Antipsychotic Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Atypical Antipsychotic Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atypical Antipsychotic Drugs Market CR5 and HHI
  16. 4.8.2 2025 Atypical Antipsychotic Drugs Tier 1, Tier 2, and Tier 3
5 Atypical Antipsychotic Drugs Market by Type
  1. 5.1 Global Atypical Antipsychotic Drugs Revenue by Type
  2. 5.1.1 Global Atypical Antipsychotic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atypical Antipsychotic Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atypical Antipsychotic Drugs Sales by Type
  6. 5.2.1 Global Atypical Antipsychotic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atypical Antipsychotic Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Atypical Antipsychotic Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atypical Antipsychotic Drugs Price by Type
6 Atypical Antipsychotic Drugs Market by Application
  1. 6.1 Global Atypical Antipsychotic Drugs Revenue by Application
  2. 6.1.1 Global Atypical Antipsychotic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atypical Antipsychotic Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atypical Antipsychotic Drugs Sales by Application
  6. 6.2.1 Global Atypical Antipsychotic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atypical Antipsychotic Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Atypical Antipsychotic Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atypical Antipsychotic Drugs Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical Industries
  2. 7.1.1 Sun Pharmaceutical Industries Company Information
  3. 7.1.2 Sun Pharmaceutical Industries Business Overview
  4. 7.1.3 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 7.2 Johnson and Johnson
  8. 7.2.1 Johnson and Johnson Company Information
  9. 7.2.2 Johnson and Johnson Business Overview
  10. 7.2.3 Johnson and Johnson Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson and Johnson Atypical Antipsychotic Drugs Product Portfolio
  12. 7.2.5 Johnson and Johnson Recent Developments
  13. 7.3 Qilu Pharmaceutical
  14. 7.3.1 Qilu Pharmaceutical Company Information
  15. 7.3.2 Qilu Pharmaceutical Business Overview
  16. 7.3.3 Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Recent Developments
  19. 7.4 Novartis AG
  20. 7.4.1 Novartis AG Company Information
  21. 7.4.2 Novartis AG Business Overview
  22. 7.4.3 Novartis AG Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis AG Atypical Antipsychotic Drugs Product Portfolio
  24. 7.4.5 Novartis AG Recent Developments
  25. 7.5 Eil Lilly and Company
  26. 7.5.1 Eil Lilly and Company Company Information
  27. 7.5.2 Eil Lilly and Company Business Overview
  28. 7.5.3 Eil Lilly and Company Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eil Lilly and Company Atypical Antipsychotic Drugs Product Portfolio
  30. 7.5.5 Eil Lilly and Company Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Atypical Antipsychotic Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Atypical Antipsychotic Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 AstraZeneca
  44. 7.8.1 AstraZeneca Company Information
  45. 7.8.2 AstraZeneca Business Overview
  46. 7.8.3 AstraZeneca Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 AstraZeneca Atypical Antipsychotic Drugs Product Portfolio
  48. 7.8.5 AstraZeneca Recent Developments
  49. 7.9 Sumitomo Dainippon Pharma
  50. 7.9.1 Sumitomo Dainippon Pharma Company Information
  51. 7.9.2 Sumitomo Dainippon Pharma Business Overview
  52. 7.9.3 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Portfolio
  54. 7.9.5 Sumitomo Dainippon Pharma Recent Developments
  55. 7.10 Sanis Health
  56. 7.10.1 Sanis Health Company Information
  57. 7.10.2 Sanis Health Business Overview
  58. 7.10.3 Sanis Health Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanis Health Atypical Antipsychotic Drugs Product Portfolio
  60. 7.10.5 Sanis Health Recent Developments
  61. 7.11 Cardinal Health
  62. 7.11.1 Cardinal Health Company Information
  63. 7.11.2 Cardinal Health Business Overview
  64. 7.11.3 Cardinal Health Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Cardinal Health Atypical Antipsychotic Drugs Product Portfolio
  66. 7.11.5 Cardinal Health Recent Developments
  67. 7.12 Bristol-Myers Squibb Company
  68. 7.12.1 Bristol-Myers Squibb Company Company Information
  69. 7.12.2 Bristol-Myers Squibb Company Business Overview
  70. 7.12.3 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Portfolio
  72. 7.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 7.13 Allergan
  74. 7.13.1 Allergan Company Information
  75. 7.13.2 Allergan Business Overview
  76. 7.13.3 Allergan Atypical Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Allergan Atypical Antipsychotic Drugs Product Portfolio
  78. 7.13.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Atypical Antipsychotic Drugs Market Size by Type
  2. 8.1.1 North America Atypical Antipsychotic Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Atypical Antipsychotic Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Atypical Antipsychotic Drugs Price by Type (2021-2032)
  5. 8.2 North America Atypical Antipsychotic Drugs Market Size by Application
  6. 8.2.1 North America Atypical Antipsychotic Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Atypical Antipsychotic Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Atypical Antipsychotic Drugs Price by Application (2021-2032)
  9. 8.3 North America Atypical Antipsychotic Drugs Market Size by Country
  10. 8.3.1 North America Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atypical Antipsychotic Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Atypical Antipsychotic Drugs Market Size by Type
  2. 9.1.1 Europe Atypical Antipsychotic Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atypical Antipsychotic Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Atypical Antipsychotic Drugs Price by Type (2021-2032)
  5. 9.2 Europe Atypical Antipsychotic Drugs Market Size by Application
  6. 9.2.1 Europe Atypical Antipsychotic Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atypical Antipsychotic Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Atypical Antipsychotic Drugs Price by Application (2021-2032)
  9. 9.3 Europe Atypical Antipsychotic Drugs Market Size by Country
  10. 9.3.1 Europe Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atypical Antipsychotic Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Atypical Antipsychotic Drugs Market Size by Type
  2. 10.1.1 China Atypical Antipsychotic Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Atypical Antipsychotic Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Atypical Antipsychotic Drugs Price by Type (2021-2032)
  5. 10.2 China Atypical Antipsychotic Drugs Market Size by Application
  6. 10.2.1 China Atypical Antipsychotic Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Atypical Antipsychotic Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Atypical Antipsychotic Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atypical Antipsychotic Drugs Market Size by Type
  2. 11.1.1 Asia Atypical Antipsychotic Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atypical Antipsychotic Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Atypical Antipsychotic Drugs Price by Type (2021-2032)
  5. 11.2 Asia Atypical Antipsychotic Drugs Market Size by Application
  6. 11.2.1 Asia Atypical Antipsychotic Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atypical Antipsychotic Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Atypical Antipsychotic Drugs Price by Application (2021-2032)
  9. 11.3 Asia Atypical Antipsychotic Drugs Market Size by Country
  10. 11.3.1 Asia Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atypical Antipsychotic Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atypical Antipsychotic Drugs Market Size by Type
  2. 12.1.1 SAMEA Atypical Antipsychotic Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atypical Antipsychotic Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atypical Antipsychotic Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Atypical Antipsychotic Drugs Market Size by Application
  6. 12.2.1 SAMEA Atypical Antipsychotic Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atypical Antipsychotic Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atypical Antipsychotic Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Atypical Antipsychotic Drugs Market Size by Country
  10. 12.3.1 SAMEA Atypical Antipsychotic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atypical Antipsychotic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atypical Antipsychotic Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atypical Antipsychotic Drugs Value Chain Analysis
  2. 13.1.1 Atypical Antipsychotic Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atypical Antipsychotic Drugs Production Mode & Process
  6. 13.2 Atypical Antipsychotic Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atypical Antipsychotic Drugs Distributors
  9. 13.2.3 Atypical Antipsychotic Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst